Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Ingredion Incorporated reported a mixed operational and financial performance for the first quarter of 2026, reflecting both challenges and areas of resilience across its business segments.</li><li>Net sales decreased by 1% year-over-year to $1.8 billion, while adjusted operating income declined 22%, largely influenced by operational difficulties at the Argo facility in the Food and Industrial Ingredients U.S./Canada segment and softer industry volumes in both U.S./Canada and Latin America.</li><li>The Argo facility’s operational challenges were the primary detractor from company-wide performance, incurring $40 million in additional costs, significantly surpassing the earlier forecast of $10 million to $15 million.</li></ul>

Ingredion Incorporated reported a mixed operational and financial performance for the first quarter of 2026, reflecting both challenges and areas of resilience across its business segments.Net sales decreased by 1% year-over-year to $1.8 billion, while adjusted operating income declined 22%, largely influenced by operational difficulties at the Argo facility in the Food and Industrial Ingredients U.S./Canada segment and softer industry volumes in both U.S./Canada and Latin America.The Argo facility’s operational challenges were the primary detractor from company-wide performance, incurring $40 million in additional costs, significantly surpassing the earlier forecast of $10 million to $15 million.

Ingredion's $40 Million Argo Hit: Can Recovery Restore Margin Momentum?